Treatment type: Cell therapies
-
Stem Cells: Hope on the horizon for preterm babies
Pioneering Australian research, undertaken by a collaboration of Monash Health’s Monash Children’s Hospital, The School of Clinical Sciences at Monash University, and Hudson Institute of Medical Research, has successfully demonstrated the feasibility and safety of using a baby’s own cord blood-derived cells as a potential treatment for extremely preterm infants.… Read more
-
Uncovering the cellular secrets of RNA editing
Professor Carl Walkley heads the RNA Biology and Innate Immune Sensing Research Group at Hudson Institute of Medical Research and their latest research, published in Science Immunology, sheds new light on these crucial processes.… Read more
-
New treatment hope for perinatal lung and brain injury
Hudson Institute researchers are lifting the lid on a treatment promising the benefits of stem cells but none of the drawbacks, offering potential to reduce the lifelong impacts of perinatal lung and brain injuries.… Read more
-
Grant to improve understanding of UCB stem cell treatment
Dr Tayla Penny will receive a grant of more than $96,000 from the Cerebral Palsy Alliance to advance her work on improving understanding of umbilical cord blood (UCB) stem cell treatment for perinatal brain injury.… Read more
-
How cell death affects your health
A/Prof Lawlor leads the Cell Death and Inflammatory Signalling Group that investigates the intricate links between cell death and inflammation and how these processes impact various inflammatory and infectious diseases. … Read more
-
Research transforming pelvic organ prolapse treatment
This research has the potential to revolutionise therapies for pelvic floor regeneration and enable personalised medicine for women.… Read more
-
World-first cord blood trial helps unborn stroke victims
When unborn babies suffer a stroke, the potential damage can be life-long, so Hudson Institute of Medical Research is aiming to change that using the stem cells found in umbilical cord blood (UCB).… Read more
-
Pelvic organ prolapse cure closer
New ways to prevent and cure pelvic organ prolapse (POP) are a big step closer, thanks to major funding for pioneering research at Hudson Institute.… Read more
-
Better treatments sooner: Hudson unveils RNAte Platform
Hudson Institute of Medical Research today officially unveiled its world-first RNAte platform that could see vaccines and therapeutic treatments developed faster by being able to rapidly assess their potential inflammation side effects, right here in Victoria.… Read more
-
Bright ideas attract major funding
Hudson Institute researchers have had some great success in the recent NHMRC Grant rounds.… Read more